Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: A population-based case-control study
Author:
Funder
Orion Pharma
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference25 articles.
1. Second cancer following cancer of the breast in Connecticut, 1935-1982;Harvey;Natl Cancer Inst Monogr,1985
2. Multiple cancer-an epidemiologic exercise in Finland;Teppo;J Natl Cancer Inst,1985
3. On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study;Adami;Br J Cancer,1987
4. Adjuvant tamoxifen in early breast cancer, occurrence of new primary cancers;Fornander;Lancet,1989
5. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14;Fisher;J Natl Cancer Inst,1994
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis;Cancer Reports;2023-03-14
2. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis;International Journal of Cancer;2022-10-24
3. Uterine Mesenchymal Tumors;Diagnostic Gynecologic and Obstetric Pathology;2018
4. Prediagnostic body size and breast cancer survival in the E3N cohort study;International Journal of Cancer;2016-05-14
5. Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation;Fitoterapia;2015-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3